Drugs Made In America Acquisition Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Drugs Made In America Acquisition Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $2.18M | Nov 18, 2025 |
| Q3 | 2025 | Jun 30, 2025 | $2.29M | Nov 18, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $2.29M | Aug 14, 2025 |
| Q3 | 2025 | Mar 31, 2025 | $1.25M | Nov 18, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $1.25M | May 20, 2025 |
| Q2 | 2025 | Mar 31, 2025 | $1.25M | Aug 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($144.9K) | Nov 18, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($54.9K) | Aug 14, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($54.9K) | Nov 18, 2025 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($263.7K) | Nov 18, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($131.9K) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($330.9K) | May 20, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($144.9K) | Nov 18, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($54.9K) | Aug 14, 2025 |